Lords Mark Secures MHRA Registration for AI Dialysis System
Lord's Mark Industries Limited has achieved a significant milestone by securing registration with the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK for its AI-powered haemodialysis system. This registration, covering Renalyx Health Systems Pvt. Ltd. and its haemodialysis system, marks India's first AI-powered dialysis ecosystem to reach this regulatory stage at this pace and positions the company for expansion into the UK and UK-allied markets. Exports are slated to begin in early January 2027. The company plans a dual business model, supplying systems to healthcare providers and establishing its own dialysis centres, aiming to participate across the renal-care value chain. This move underscores Lord's Mark's strategy of developing advanced Indian medical technologies for global impact.
Key Highlights
- MHRA registration secured for AI-powered haemodialysis system.
- Gateway to UK and UK-allied markets opens for exports starting Jan 2027.
- Company plans dual business model: system supply and dialysis centre operations.
- Milestone achieved at unprecedented pace for an Indian AI dialysis ecosystem.
- Positions India's medical technology sector for global renal-care opportunities.
Price Impact
More from LORDSMARK